
WASHINGTON, March 7, 2008
Prescription For Profit
Meet The Whistleblower Who Exposed A Hospital's Dangerous, And Costly, Pill Swapping
-
Play CBS Video Video A Doctor's Fight Pays Off It's a David and Goliath story between one doctor and a widespread medical practice, one that puts profit ahead of health and costs taxpayers millions of dollars. Sharyl Attkisson reports.
-
-
William LaCorte blew the whistle on one New Orleans hospital's prescription-swapping scheme, which was costing taxpayers big. (CBS)
-
(CBS/iStockphoto)
-
-
Interactive HealthWatch Explore health issues including AIDS, cancer and antibiotics.
-
Blog Primary Source Armen Keteyian and his investigative team keep you informed daily on their blog.

• Murtha's Defense Earmarks Questioned
• Bailout Banks Hike Up Charges
• Student Loan Charity Under Fire
• Bailout Money To Tax Havens
• Big Bank's Bailout Spending Spree
• The Impossible-To-Track Bailout
• Where Did The Bailout Billions Really Go?
• Pension System A Runaway Train
• Parking Garage To Nowhere
• Did D.C. Bribery Cost Troop Lives?
• Teach For America Gets Schooled
• USDA Jobs A Day At The Beach?
• From Lawmaker To Lobbyist
• Flying The Empty Skies
• Fishing For Tax $$
• Millions In Pills, Flushed
"It's amazing that any pharmaceutical reps call on me at all," he said.
He's been fighting a one-man battle against a widespread medical practice. It puts profit ahead of health and costs you hundreds of millions of dollars, CBS News correspondent Sharyl Attkisson reports.
"I may be just a big pain in the ass," he said.
It started when he caught Memorial Hospital in New Orleans doing something very odd.
Every time he prescribed Zantac, the hospital changed it to Pepcid. Both are acid blockers than can prevent dangerous internal bleeding.
"I said, 'why is it I'm ordering one drug and a totally different drug is being given?'" LaCorte said. "And I was told 'therapeutic interchange.'"
Therapeutic interchange meant the hospital was switching virtually all antacid prescriptions to Pepcid. And it wasn't a meaningless change.
While LaCorte says Pepcid is a good drug, it was given in doses that were too strong for some patients, making them very sick. One even went into a coma.
When he tried to find out why so many were given Pepcid, he discovered Memorial Hospital had made what's called a "market share" deal with Merck, the maker of the drug. As long as 80 percent of patients were on Pepcid, Merck gave the hospital a deep discount.
The hospital's task was to get almost all of the patients who needed that type of drug on the Merck brand drug, according to LaCorte.
LaCorte complained to everyone he could think of … without result.
Finally, he got the feds involved - by proving taxpayers were being defrauded. It turns out the Pepcid cost twice as much as Zantac, and since many patients were on Medicaid or Medicare, taxpayers covered the extra cost.
The fight took 12 long years, but Merck recently agreed to pay back taxpayers $650 million for deals to get hospitals nationwide to favor not only Pepcid, but also Merck drugs Zocor and Vioxx.
Under U.S. law for whistleblowers, LaCorte will get a sizable payment from the recovered money.
"This is a widespread practice with multiple medications," he said. "This is business-as-usual for the hospitals and drug companies in the United States of America today."
LaCorte says taking them on is tougher than fighting City Hall.
But he's just the doctor with the bedside manner to do it.
© MMVIII, CBS Interactive Inc. All Rights Reserved.
- I have worked in "Mission based" health care for 35 years. As a pharmacy director, controlling our formulary cost is one of the most important things we do to ensure we can provide medical care to every one that enters our door. I am a little confused by the "PROFIT" comments about TI. In California, most government sponsored insurance pays a DRG or a Per Diem rate for a patient''s hospital visit. Pharmacy is no longer considered a revenu producer but a cost center. We spend considerable effort counter detailing the "latest & greatest" medication that hits the market. The drug inndustry has stopped much of the "free stuff" for physician''s and pharmacists but I imagine it still exists. I suggest to the critics of TI, to call their local, "mission based" hospital pharmacy director and schedule a meeting to discuss. The discussion might go differently at a hospital the is "profit" oriented.
- Reply to this comment
- This isn''t a blanket criticism on TI, but just as it concerns medicare and public spending. You''ll notice it''s part of Atkinson''s follow the money series, which is one of the my favorite CBS segments. It''s not about medical malpractice, though there are implications for that.
If you follow the money, it''s clear that the hospital''s saving money because they''re getting a kick-back from Merck. And Merck is making money because they''re selling more goods. The average medicare patient is unaffected, because they wouldn''t be paying for their drugs anyway. The money that Merck, and consequently the hosptial, are making comes from the taxpayer.
I''m not on medicare, I pay for my own drugs through insurance or directly. If I were particularly vigilant, I might notice that I could save more money in the long term by getting the prescription from a non-hosptial pharmacy, just as I might buy clothes from a store that had a sale. That''s how capitalism works.
However, a medicare patient has no incentive to save money, and in all likelihood may be too old to seek out a cheaper price.
Neither the hosptial, nor Merck, nor patients have a direct incentive to blow the whistle, even though taxpayers are losing out. That''s why Lacorte did an admirable deed, and deserves a financial reward. - Reply to this comment
- No one is hurt by this? What about us taxpayers who payed twice as much for people to be on pepcid?
- Reply to this comment
- It''s unfortunate that this type of hype is given to a routine practice at every hospital across the country. This practice of substituting one drug for other drugs in the same therapuetic class actually saves the patients, the hospital, and the insurance companies (state, federal or private) money while providing the same level of care to the patient. What the good doctor fails to tell us is how much money was saved on the other Merck medications given at the hospital during that period of time. It''s also very easy to blame Pepcid for causing a coma, yet what other dugs was the patient on, or what other conditions did the patient have that may have led to a coma? Did he rule out all of those other causes. The other thing he doesn''t mention is that these substitutions don''t go on without anyone''s knowledge. They are always approved by the pharmacy and the medical staff. Let''s remember that the settlement was against Merck for their dealings and not against the hospital for its practices. And for those who think they should get what ever they want when they go into a hospital, they should remember that the care you receive is based on the policies and procedures of the hospital which you provider must agree to follow in order to have the ability to care for patients there. Just the same as Lacorte did. He seems to have had a vendetta against a few people. I hope every who takes Mercks products now is happy, wait until the cost goes up to cover the cost of the settlements :).
- Reply to this comment
- I don''t know about prescription drug switching, but I do know about hospitals padding bills with services that WERE NOT USED.
- Reply to this comment
- As a Pharmacist at a small non-profit community hospital, we rely on the practice of therapeutic interchange (TI) to allow us to safely provide our patients with medications. It is true that TI usually is designed to same money by allowing the pharmacy to stock a limited number of medications, but what has been lost here is the safety advantage of this practice. Despite what was reported in this story, TI has safety advantages! Hospitals are required by The Joint Commission to have a formulary. The formulary process at a hospital involves providing Prescribers, Nurses, and Pharmacists with drug information, including patient counseling information for each medication on the formulary. It would be nearly impossible for a hospital Nurse to stay aware of every medication on the market. The hospital staff relies on the P&T committee to make sure that if a medication is available in a hospital, then nurses know how to use the medication and what to look for as far as side effects. Stocking all medications would be detrimental to patient safety as well as being financially irresponsible to the hospital. Even the most state of the art hospital does not stock every medication on the market %u2013 it would be unwise and unsafe! I would hope that the producers of CBS evening news would report the whole story, not just sensational stories that promote distrust and fear.
- Reply to this comment
- Posters: I am a nurse. Please go back and read the posts of whunt31045 and ldharlow. They know what they are talking about and what they say is correct. No one is harmed by this practice and it lowers a patient''s hospital bill.
- Reply to this comment
- Business as Usual...Outrageous I''m glad he ratted them out and The Justice Department sued them!
- Reply to this comment
- Dr. Lacorte is one of the most unethical, unprofessional physicians in all of New Orleans. He has become a millionare off of the taxpayers $$$ due to his prolonging the life of soo many terminal patients. He gives families false hope to make more money. I can''t believe he won this law suit!!!! There''s no way that pepcid puts anyone into a coma... Seriously...... I bet if you look into this patients'' status, they were probably terminal with multiple debilitating problems.... This report disgusts me along with many health care professionals who know the real Lacorte.
I''ve lost respect for Katie and the CBS news for this horrible story........ - Reply to this comment
Ex-NBA ref Tim Donaghy 



